|Articles|October 24, 2018

New Jersey Department of Health Investigates Adenovirus Outbreak

The New Jersey Department of Health has confirmed 18 cases of human adenovirus type 7 in pediatric patients.

Updated: November 1, 2018 at 4:30 PM EDT

Health officials in New Jersey are investigating an ongoing human adenovirus outbreak that has already claimed the lives of 9 children at a nursing and rehabilitation center.

Today, October 23, 2018, the New Jersey Department of Health (NJDOH) confirmed 27 cases associated with this outbreak that has sprung up at the Wanaque Center for Nursing and Rehabilitation in Haskell, NJ.

In a statement, the NJDOH announced that the outbreak strain is human adenovirus type 7, which has been associated with diseases in communal living arrangements and can be severe in immunocompromised patients, including the “medically fragile” pediatric population at the facility.

Adenoviruses are commonly associated with acute respiratory infections disease, according to the US Centers for Disease Control and Prevention (CDC).

Currently, there is no adenovirus vaccine available for the general public. Previously, a vaccine developed to provide protection against human adenovirus types 4 and 7 was given to recruits of the US military from 1971 to 1999 but has since been discontinued. In 2011, a novel oral vaccine designed to protect against strains 4 and 7 was approved by the US Food and Drug Administration; however, the vaccination is only authorized to be administered in military personnel who may be at a higher risk for becoming infected with a strain.

The CDC also indicates that there is no specific treatment for individuals who fall ill with human adenovirus infections. Mild infections typically do not require medical care, but in immunocompromised patients, cidofovir has been used to treat patients in specific situations.

During a visit to the facility on Sunday, health officials observed minor handwashing deficiencies and are continuing to implement infection control measures at the facility, according to the NJDOH. Adenoviruses can be resistant to common disinfectants and persist on surfaces and medical instruments for long periods of time.

The DOH has mandated that the facility refrain from admitting any new patients until the outbreak has come to an end.

This is an ongoing investigation and updates will be provided as they become available.

For the most recent case counts associated with the Adenovirus Strain 7 Outbreak in New Jersey, check out the Contagion® Outbreak Monitor.


Related to this article

How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.